Introduction
B-1 (CD5 ϩ B) cells have several unique features that distinguish them from B-2 (conventional B) cells. First, B-1 cells are suggested to originate from progenitors in the fetal omentum, para-aortic splanchnopleura or the peritoneal cavity (1-3), while progenitors for B-2 cells are mainly localized in the fetal liver or adult bone marrow (4) . Second, differentiation into B-1 and B-2 cells may be regulated by different genes because Btk-deficient mice lack B-1 cells (5-7), whereas most of the peripheral B cells are B-1 cells in hematopoietic cell phosphatase (also called PTP1C and SHP)-deficient motheaten mice (8) . Third, growth factors for B-1 cells are different from those for B-2 cells. B-1 cells but not B-2 cells express IL-5 receptors and respond to IL-5 (9) . IL-10 may also be involved in development of B-1 cells as continuous administration of anti-IL-10 antibody depletes peritoneal B-1 cells (10) . Fourth, B-1 cells use a more restricted repertoire of V genes than B-2 cells. For example, 5-15% of the peritoneal B-1 cells react with bromelain-treated mouse red blood cells (BrMRBC) (11) , and the specificity is almost Correspondence to: T. Honjo Transmitting editor: T. Watanabe Received 17 March 1998, accepted 7 April 1998 exclusively associated with the expression of V H 11/V κ 9 and V H 12/V κ 4 genes (12,13) B-1 cells play important roles in protection from natural infection of bacteria. B-1 cells produce around one half of natural serum IgM (14, 15) , which recognize bacterial cell wall components (16, 11) . The B-1 cells reactive to phosphatidylcholine expand preferentially in the peritoneal cavity in postnatal life, presumably in response to bacterial antigens (13, 17) . B-1 cells are abundant in gut-associated lymphoid tissues (GALT) and are involved in mucosal immunity. Most of the IgA-producing cells in the lamina propria of the gut are derived from B-1 cells (18) . Moreover, a defective mucosal IgA response to oral immunization with Salmonella typhimurium in xid mice was rescued by transferring peritoneal B-1 cells from normal mice (19) .
B-1 cells have been suggested to play autopathogenic roles in autoimmune diseases. The numbers of B-1 cells are shown to increase in autoimmunity-prone NZB and (NZBϫNZW)F 1 (NZB/WF1) mice (20) , which spontaneously develop autoimmune hemolytic anemia and systemic lupus erythematosus respectively, as well as in patients of autoimmune diseases such as rheumatoid arthritis (21) and Sjö gren syndrome (22) . In both mouse and human, autoantibodies such as anti-DNA and anti-BrMRBC antibodies, and rheumatoid factor are often produced by B-1 cells (23) (24) (25) .
In anti-RBC Ig (H ϩ L chains) transgenic mice (HL mice), peripheral B-2 cells are clonally deleted but peritoneal B-1 cells escape from deletion and expand to a considerable number by 8 weeks of age (26, 27) . Peritoneal B-1 cells are responsible for autoimmune anemia in HL mice because depletion of peritoneal B-1 cells by RBC injection cured autoimmune anemia in HL mice (27) . Autoimmune anemia is aggravated by oral administration of lipopolysaccharide (LPS) in HL mice but not xidϫHL mice lacking B-1 cells (28) . LPS in the gut lumen activates B-1 cells in GALT. Since about half of HL mice develop autoimmune anemia under conventional conditions while no anemic HL mice were found under specific pathogen-free or germ-free conditions (26, 29) , environmental bacteria are suggested to activate peritoneal B-1 cells and to induce autoimmune anemia in HL mice. In HL mice maintained under conventional conditions, environmental bacterial antigens may stimulate peritoneal B-1 cells to differentiate into Ig-producing cells. T h 2 cell-derived cytokines such as IL-5 and IL-10 are also involved in activation of peritoneal B-1 cells, because administration of these cytokines activated peritoneal B-1 cells and induced autoimmune anemia in HL mice (30) . On the other hand, IL-4 does not stimulate B-1 cells in HL mice. Although multiple factors are suggested to be responsible for autoimmune anemia in HL mice, it has not yet been made clear how these factors induce the autoimmune disease in HL mice.
To dissect molecular mechanisms of B-1 cell activation in HL mice, we crossed HL mice with RAG-2 -/-mice which lack mature T and B cells. Surprisingly, the numbers of peritoneal B-1 cells expressing the transgene are drastically reduced in RAG-2 -/-ϫHL mice. Using this recombinant mouse, we have shown that T cells are required for proliferation and activation of peritoneal B-1 cells, in which IL-10 plays an essential role.
Methods

Animals
The transgenic mouse line carrying either Ig H or L chain gene for an anti-erythrocyte mAb (4C8 mAb) was established by Okamoto et al. (26) . HL mice were backcrossed with C57BL/6 for Ͼ12 generations. RAG-2 -/-mice were kindly donated by F. W. Alt (31) and backcrossed with C57BL/6 for more than six generations. Both strains are maintained in our animal colony under conventional conditions.
Antibodies
Antibodies used in this study were rat anti mouse B220 (RA3-6B2), rat anti-mouse Mac-1, FITC-labeled mAb mouse anti-rat κ chain (Cosmo-Bio., Tokyo, Japan), phycoerythrin (PE)-labeled goat anti-mouse IgM antibody (Southern Biotechnology Associates, Birmingham, AL), FITC-labeled hamster anti-mouse CD3ε antibody (PharMingen, San Diego, CA), goat anti-mouse IgM antibody (Cappel, Durham, NC), FITClabeled rat anti-mouse CD8 mAb (Gibco/BRL, Gaithersburg, MD), PE-labeled rat anti-mouse CD4 mAb (PharMingen, San Diego, CA), rat anti-mouse IL-10 mAb (Genzyme, Cambridge, MA), rat IgG (Inter-cell Technologies, Hopewell, NJ) and S54 anti-4C8 (HL) idiotype mAb (26) .
Flow cytometry
Cells from the spleen, the bone marrow, inguinal lymph nodes, peripheral blood and the peritoneal cavity of mice were applied to Ficoll-Hypaque gradient centrifugation, and mononuclear cells enriched at the interface layer were used for flow cytometric analysis. Single-cell suspensions were stained with appropriate antibodies and analyzed by FACScan (Becton Dickinson, Mountain View, CA) after exclusion of dead cells by propidium iodide gating. Two-color staining of mononuclear cells with anti-B220 and anti-IgM, anti-Mac-1 and anti-IgM, and anti-CD8 and anti-CD4 antibodies were done as described previously (26, 32, 33) .
Administration of LPS, cholera toxin, IL-5, IL-10 and anti-IL-10 antibody LPS (Escherichia coli serotype 026B6; Sigma, St Louis, MO), 10 µg, was orally administrated into RAG-2 -/-ϫHL mice and RAG-2 -/ϩ ϫHL mice of 8 weeks of age. IL-5 (Genzyme, Cambridge, MA) (20,000 U) or IL-10 (10 µg; kindly donated by Dr H. Ishida) was administrated intramuscularly into RAG-2 -/-ϫHL mice and RAG-2 -/ϩ ϫHL mice. Either anti-IL-10 mAb (100 µg/injection) or control rat IgG (100 µg/injection) was injected i.p. into HL mice.
Immunospot and ELISA
The numbers of antibody-producing cells in 10 5 cells of the peritoneal cavity and the amount of Ig-producing cells from mice at 8 weeks of age were analyzed with enzyme-linked immunospot assay using the S54 mAb specific to the 4C8 idiotype as described previously (27) . ELISA assay of the anti-RBC Ig (IgM) was carried out with the S54 mAb on the plate, followed by the addition of alkaline phosphatasecoupled goat anti-mouse IgM (Cappel) and Sigma 104 phosphatase substrate (Sigma). Amounts of IL-5 and IL-10 in the serum from mice were assessed using the mouse IL-5-or IL-10-ELISA system (Amersham, Amersham, UK) according to the manufacturer's protocol.
Immunohistochemistry
The small intestines from mice were embedded with Tissue Tek OCT compound (Miles, West Haven, CT), frozen in liquid nitrogen and cut into 5 µm sections. These sections were airdried, acetone-fixed and treated with 0.3% hydrogen peroxide in absolute methanol to inhibit the activity of endogenous peroxidase. To block non-specific binding between avidin and endogenous biotin or lectins in the section, the slides were incubated with the avidin-biotin blocking kit (Vector, Burlingame, CA). The sections were incubated with biotinylated goat anti-mouse IgM antibody (Cappel, Durham, NC) and then incubated with streptoavidin biotinylated horseradish peroxidase complex (Amersham). Finally, the sections were incubated with 0.1% 3,3Ј-diaminodenzidine:tetrahydrochloride containing 0.02% hydrogen peroxide in 0.1 M Tris buffer, pH 7.2, for the visualization of reaction products and Transplantation of fetal thymus C57BL/6 mice in day 17 pregnancy were purchased from Shimizu Laboratory Animals (Kyoto, Japan). Both thymic lobes were removed from fetal mice and transferred to the kidney subcapuslar region of RAG-2 -/-and RAG-2 -/-ϫHL mice as described in Takeda et al. (34) .
Results
B cell tolerance in RAG-2 -/-ϫHL mice
To study the influence of other lymphocytes on activation of B-1 cells in HL transgenic mice, we examined RAG-2 -/-ϫHL mice generated by the cross between HL and RAG-2 -/-mice. Mice were maintained under conventional conditions in our animal facility until they were sacrificed for experiments at 8 weeks of age. RAG-2 -/-ϫHL mice lack T cells because of the RAG-2 -/-background, but B cells are complemented by Ig H and L chain transgenes. As all B cells in RAG-2 -/-ϫHL mice express anti-RBC Ig, B cells in the spleen, the bone marrow and lymph nodes of RAG-2 -/-ϫHL mice are completely deleted by exposure to RBC (Fig. 1) . Since the HL transgene almost completely suppress the rearrangement of the endogenous Ig loci (26) , only a small number, if any, of endogenous Ig-bearing B cells that escaped from allelic exclusion existed in RAG-2 -/ϩ ϫHL mice. Indeed these B cells were not stained with the S54 mAb (data not shown). These results indicate that clonal deletion of self-reactive B cells Peritoneal B-1 cell deficiency in RAG-2 -/-ϫHL mice As peritoneal B-1 cells are responsible for autoimmune hemolytic anemia in HL mice, the peritoneal B-1 cells from RAG-2 -/-ϫHL mice were analyzed by flow cytometry. To our surprise, almost all B-1 cells disappeared in the peritoneal cavity of RAG-2 -/-ϫHL mice ( Fig. 2A) , whereas the B-1 cell level in the peritoneal cavity of RAG-2 -/ϩ ϫHL mice was the same as that of HL mice (26) . Almost all peritoneal B cells were stained with the S54 mAb (data not shown) in agreement with the previous results (26, 28) .
Furthermore, anti-RBC Ig-producing cells were undetectable in the peritoneal cavity of RAG-2 -/-ϫHL mice, while RAG-2 -/ϩ ϫHL mice contained the same level of anti-RBC Igproducing cells (17.5 Ϯ 5/10 5 peritoneal cells) as HL mice (Fig. 3A) (26) . The numbers of peritoneal IgM-producing cells did not differ significantly from those of peritoneal anti-RBC Ig-producing cells in both RAG-2 -/ϩ ϫHL and RAG-2 -/-ϫHL mice (data not shown), because endogenous Ig gene rearrangements are strongly suppressed by transgenic Ig expression in these mice (26) . The amount of the anti-RBC antibody in the serum of RAG-2 -/-ϫHL mice was only 13% of that in the serum of RAG-2 -/ϩ ϫHL mice (0.73 Ϯ 0.19 mg/ml) (Fig. 3B) . As expected, none of the RAG-2 -/-ϫHL mice developed autoimmune hemolytic anemia even under conventional conditions. These results indicate that either T or other types of B cells are required for development and maturation of B-1 cells in the peritoneal cavity. Restoration of peritoneal B-1 cells in RAG-2 -/-ϫHL mice by fetal thymus transfer To see whether the T cell deficiency is the main cause of the disappearance of peritoneal B-1 cells in RAG-2 -/-ϫHL mice, we transferred day 17 fetal thymus to RAG-2 -/-ϫHL mice. Six weeks after the fetal thymus transfer, the number of peritoneal B-1 cells in RAG-2 -/-ϫHL mice recovered to about half as many as those in RAG-2 -/ϩ ϫHL mice in parallel with appearance of a comparable number (7.8ϫ10 5 ) of peritoneal T cells with those in HL mice (1.3ϫ10 6 ) (Fig. 4) . In contrast, peritoneal B220 ϩ IgM ϩ B cells were undetectable in control RAG-2 -/-mice 6 weeks after fetal thymus transfer. The increase in B cells in thymus-transferred RAG-2 -/-ϫHL mice was shown to be due to B-1 cells as they were Mac-1 ϩ . In addition, the numbers of peritoneal anti-RBC Ig-producing cells and serum anti-RBC Ig levels in thymus-transferred RAG-2 -/-ϫHL mice reached nearly the same level as those in RAG-2 -/ϩ ϫHL mice (Fig. 3) . These results strongly indicate that T cells play essential roles in assisting proliferation and differentiation of peritoneal B-1 cells in HL mice under conventional conditions.
Restoration of peritoneal B-1 cells in RAG-2 -/-ϫHL mice by LPS LPS is known to induce differentiation of B-1 cells in GALT in HL mice (28) as well as normal mice (37, 38) . We therefore examined whether the peritoneal B-1 cell deficiency in RAG-2 -/-ϫHL could be overcome by oral administration of LPS. The numbers of B-1 cells in the peritoneal cavity (Fig. 2B) and IgM ϩ B cells in the lamina propria of the gut (Fig. 5 ) markedly increased 1 week after administration of LPS. The numbers of peritoneal anti-RBC Ig-producing cells and amounts of serum anti-RBC Ig also increased markedly 1 week after LPS administration (Fig. 3) . In parallel with these changes, hematocrit values drastically decreased in RAG-2 -/-ϫHL mice as well as RAG-2 -/ϩ ϫHL mice 1 week after LPS administration (Table 1) (Fig. 2B) . The numbers of anti-RBC Ig-producing cells in the peritoneal cavity as well as the amounts of anti-RBC Ig in the sera in IL-5-or IL-10-administered RAG-2 -/-ϫHL mice increased to 60-70% of those of IL-5-or IL-10-administered RAG-2 -/ϩ ϫHL mice (Fig. 3) . Administration of IL-5 or IL-10 decreased hematocrit values in RAG-2 -/-ϫHL mice, indicating that IL-5 or IL-10 induced autoimmune anemia (Table 1) . These results show that IL-5 and IL-10 induce proliferation and differentiation of peritoneal self-reactive B-1 cells even in the T cell-deficient mice.
Involvement of IL-10 in autoimmune hemolytic anemia induction in HL mice
To see whether IL-10 is involved in peritoneal B-1 cell proliferation in HL mice maintained under conventional conditions, we Fig. 4 . Flow cytometry analysis of peritoneal cells of fetal thymus transferred RAG-2 -/-and RAG-2 -/-ϫHL mice, and non-treated RAG-2 -/ϩ ϫHL mice. Day 17 fetal thymi were transferred to RAG-2 -/-and RAG-2 -/-ϫHL mice. Six weeks after transferring fetal thymi, peritoneal cells from RAG-2 -/-and RAG-2 -/-ϫHL mice were stained with the anti-B220 (6B2) or anti-Mac-1 antibody, followed by FITC-labeled mouse anti-rat κ chain and PE-labeled goat anti-mouse IgM antibodies. Peritoneal cells are also stained with FITC-labeled anti-mouse CD8 mAb and PElabeled anti-mouse CD4 mAb. Percentages of B220 ϩ IgM ϩ cells, Mac-1 ϩ IgM ϩ cells, CD4 ϩ cells and CD8 ϩ cells are indicated.
injected an anti-IL-10 mAb (100 µg/injection) weekly for 4 weeks. Interestingly, the frequency of peritoneal B-1 cells drastically reduced, while control rat IgG injection did not affect the peritoneal B-1 cell frequency greatly (Fig. 6) . These results suggest that IL-10 is involved in T cell-dependent proliferation of B-1 cells in HL mice.
We then examined whether IL-10 is also involved in peritoneal B-1 cell activation by LPS in RAG-2 -/-ϫHL mice. LPS induced a significant increase of the serum IL-10 level in RAG-2 -/-ϫHL mice as well as the other parental lines including HL mice ( Table 2) . Levels of IL-5 in the sera of RAG-2 -/-mice, RAG-2 -/-ϫHL mice, C57BL/6 mice and HL mice were below the detectable level (20 pg/ml) even after LPS administration. To see whether or not IL-10 is involved in the LPS-induced onset of autoimmune anemia in HL mice, we neutralized IL-10 by administration of the anti-IL-10 mAb. We injected 100 µg of the anti-murine IL-10 antibody into HL mice i.p. 24 h before, and 24 and 72 h after oral administration of LPS. We measured hematocrit values 7 days after LPS administration. IL-10 neutralization almost completely blocked reduction of hematocrit values of LPS-administered HL mice, while hematocrit values of LPS-treated HL mice which received rat IgG as a control decreased drastically (Table 3) . IL-10 neutralization also suppressed the LPS-induced increase in the amount of anti-RBC Ig and the number of anti-RBC Ig-producing cells in the peritoneal cavity of HL mice (Table 3) . These results clearly demonstrate that elevation of the IL-10 level is responsible for induction of autoimmune anemia in HL mice. Amounts of IL-5 and IL-10 in the sera from non-treated mice and LPS (10 µg)-administered mice were measured 7 days after administration. Values represent the mean value Ϯ SD of IL-5 or IL-10 (pg/ml) in the serum from three mice in each experimental group.
Paired t-test values as compared to non-treated mice are: a P Ͻ 0.01. Either anti-IL-10 mAb (100 µg) or control rat IgG (100 µg) was injected i.p. into HL mice on day -1, 1 and 3. On day 0, LPS (10 µg) was orally administrated into HL mice. PBS-treated (p.o.) HL mice were used as a control. Hematocrit values (%) were measured at day 0 and 7 days after administration of LPS or PBS. Amounts of anti-RBC Ig in the serum were determined by ELISA using S54 anti-RBC idiotype antibody. (Table 2) . LPSinduced autoimmune anemia as well as peritoneal B-1 cell activation in HL mice is blocked by administration of the anti-IL-10 mAb. Since RAG-2 -/-ϫHL mice lack T cells, LPS stimulates non-T cells to secrete IL-10 in these mice. It is known that sorted peritoneal macrophages secrete IL-10 upon stimulation by LPS (40) . Moreover, LPS-induced serum IL-10 levels in normal mice are effectively blocked by administration of a neutralizing antibody against tumor necrosis factor-α (41), which is known to suppress LPS-induced IL-10 secretion by macrophages in vitro (42, 43) . B-1 cells per se also respond to LPS by secreting IL-10 in vitro (44) . However, it is unlikely that the small number of B-1 cells in RAG-2 -/-ϫHL mice can account for the observed IL-10 concentrations required for rapid B-1 cell proliferation, because the number of B-1 cells in RAG-2 -/-ϫHL mice are very low (0.8%) and reach the wild-type level (20%) 1 week after LPS stimulation. It is, therefore, likely that LPS stimulates macrophages to secrete IL-10.
Mechanisms of B-1 cell activation by IL-10
Our preliminary experiments indicate that IL-10 neither elicits In vitro experiments show that freshly isolated peritoneal B-1 cells proliferate, differentiate and secrete autoantibodies in response to IL-5 (47) . Taken together, IL-5 as well as IL-10 is suggested to be involved in activation of peritoneal B-1 cells in the T cell-dependent pathway.
In conclusion, we have shown that peritoneal B-1 cells in HL mice proliferate and secrete Ig in a T-dependent manner. We provide evidence that IL-10 plays a pivotal role in proliferation and activation of B-1 cells in HL mice. Future experiments will be focused on identification of other cytokines which may be induced by and/or synergize with IL-10 to activate B-1 cells in vivo.
